EDMP Inc’s AstraZeneca AZN Stock Holding History

EDMP Inc’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,070	Closed	-$1.59M	–	66
2024 Q3	$1.59M	Hold	10,070	–	–	1.31%	30
2024 Q2	$1.54M	Hold	10,070	–	–	1.4%	27
2024 Q1	$1.36M	Sell	10,070 -311	-3%	-$41.2K	1.14%	30
2023 Q4	$1.39M	Sell	10,381 -214	-2%	-$27.8K	1.26%	28
2023 Q3	$1.45M	Sell	10,595 -683	-6%	-$93.3K	1.48%	25
2023 Q2	$1.62M	Sell	11,278 -29	-0.3%	-$4.27K	1.54%	24
2023 Q1	$1.56M	Sell	11,307 -576	-5%	-$77.5K	1.56%	25
2022 Q4	$1.61M	Sell	11,883 -364	-3%	-$45.6K	1.59%	24
2022 Q3	$1.34M	Sell	12,247 -274	-2%	-$34.8K	1.43%	28
2022 Q2	$1.66M	Sell	12,521 -77	-0.6%	-$10.1K	1.62%	27
2022 Q1	$1.67M	Sell	12,598 -143	-1%	-$17.1K	1.57%	28
2021 Q4	$1.48M	Sell	12,741 -1,029	-7%	-$121K	1.48%	30
2021 Q3	$1.65M	Buy	+13,770	New	+$1.6M	1.75%	27

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

EDMP Inc's AZN Position: Q4 2024 in Review

EDMP Inc sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 10,070 shares — an estimated $1.59M sold.

EDMP Inc first reported a position in AZN in Q3 2021 and held it in 13 quarters. The position peaked at $1.67M in Q1 2022. 1,219 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

EDMP Inc reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
EDMP Inc sold 10,070 AstraZeneca shares in Q4 2024, an estimated $1.59M.
EDMP Inc first reported a position in AstraZeneca in Q3 2021 and held it in 13 quarters.
EDMP Inc's AstraZeneca position peaked at $1.67M in Q1 2022.
1,219 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on EDMP Inc's 13F filing for Q4 2024, filed 29 Jan 2025.